体外艾塞那肽对1型糖尿病患者外周血单个核细胞的免疫调节作用

目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研究Exendin-4对PBMC的作用.通过Western blotting检测胰高血糖素样肽1受体(GLP-1R)的表达情况;根据检测PBMC中环磷酸腺苷(cAMP)的浓度设置不同Exendin浓度干预组(0、10、100 nmol/L)及拮抗剂组[50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4];实时荧光定量聚合酶链反应(PCR)和细胞因子微球检测技术分别测定Exend...

Full description

Saved in:
Bibliographic Details
Published in中华糖尿病杂志 Vol. 9; no. 10; pp. 617 - 621
Main Author 李霞;雷康;俞海波;段仙兰;彭亚妮;周智广
Format Journal Article
LanguageChinese
Published 中南大学湘雅二医院内分泌代谢科中南大学糖尿病免疫学教育部重点实验室国家代谢性疾病临床医学研究中心, 长沙,410011 2017
Subjects
Online AccessGet full text
ISSN1674-5809
DOI10.3760/cma.j.issn.1674-5809.2017.10.005

Cover

Abstract 目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研究Exendin-4对PBMC的作用.通过Western blotting检测胰高血糖素样肽1受体(GLP-1R)的表达情况;根据检测PBMC中环磷酸腺苷(cAMP)的浓度设置不同Exendin浓度干预组(0、10、100 nmol/L)及拮抗剂组[50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4];实时荧光定量聚合酶链反应(PCR)和细胞因子微球检测技术分别测定Exendin-4干预前后细胞因子[白细胞介素(IL)10、肿瘤坏死因子(TNF)α]在胞内和上清中的变化情况.两组间比较采用t检验,多组间比较采用方差分析.结果(1)T1DM患者PBMC表达GLP-1R,与对照组(0 nmol/L)相比,100 nmol/L Exendin-4干预组GLP-1R表达显著上升(1.97±0.24比1;t=13.89,P〈0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(0.56±0.10比1, t=15.68,P〈0.05).(2)与对照组相比,1、10、100 nmol/L浓度Exendin-4对T1DM患者PBMC活力无明显影响(F=0.362、0.393、0.374,均P〉0.05).(3)与对照组相比,10、100 nmol/L Exendin-4上调PBMC中cAMP水平(7.51±0.01比2.56±0.01,17.21±0.04比2.56±0.01,t=19.71、32.89,P〈0.05).(4)与对照组相比,Exendin-4显著下调PBMC细胞中TNF-α mRNA及上清液中TNF-α水平(F=5.54、5.12,P〈0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(F=5.43、5.97,P〈0.05);同时Exendin-4可上调上清液中IL-10水平(F=5.95、6.01,P〈0.05).结论 Exendin-4可上调IL-10的分泌,下调TNF-α的分泌,提示其可能抑制炎症反应.
AbstractList 目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研究Exendin-4对PBMC的作用.通过Western blotting检测胰高血糖素样肽1受体(GLP-1R)的表达情况;根据检测PBMC中环磷酸腺苷(cAMP)的浓度设置不同Exendin浓度干预组(0、10、100 nmol/L)及拮抗剂组[50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4];实时荧光定量聚合酶链反应(PCR)和细胞因子微球检测技术分别测定Exendin-4干预前后细胞因子[白细胞介素(IL)10、肿瘤坏死因子(TNF)α]在胞内和上清中的变化情况.两组间比较采用t检验,多组间比较采用方差分析.结果(1)T1DM患者PBMC表达GLP-1R,与对照组(0 nmol/L)相比,100 nmol/L Exendin-4干预组GLP-1R表达显著上升(1.97±0.24比1;t=13.89,P〈0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(0.56±0.10比1, t=15.68,P〈0.05).(2)与对照组相比,1、10、100 nmol/L浓度Exendin-4对T1DM患者PBMC活力无明显影响(F=0.362、0.393、0.374,均P〉0.05).(3)与对照组相比,10、100 nmol/L Exendin-4上调PBMC中cAMP水平(7.51±0.01比2.56±0.01,17.21±0.04比2.56±0.01,t=19.71、32.89,P〈0.05).(4)与对照组相比,Exendin-4显著下调PBMC细胞中TNF-α mRNA及上清液中TNF-α水平(F=5.54、5.12,P〈0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(F=5.43、5.97,P〈0.05);同时Exendin-4可上调上清液中IL-10水平(F=5.95、6.01,P〈0.05).结论 Exendin-4可上调IL-10的分泌,下调TNF-α的分泌,提示其可能抑制炎症反应.
目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研究Exendin-4对PBMC的作用.通过Western blotting检测胰高血糖素样肽1受体(GLP-1R)的表达情况;根据检测PBMC中环磷酸腺苷(cAMP)的浓度设置不同Exendin浓度干预组(0、10、100 nmol/L)及拮抗剂组[50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4];实时荧光定量聚合酶链反应(PCR)和细胞因子微球检测技术分别测定Exendin-4干预前后细胞因子[白细胞介素(IL)10、肿瘤坏死因子(TNF)α]在胞内和上清中的变化情况.两组间比较采用t检验,多组间比较采用方差分析.结果(1)T1DM患者PBMC表达GLP-1R,与对照组(0 nmol/L)相比,100 nmol/L Exendin-4干预组GLP-1R表达显著上升(1.97±0.24比1;t=13.89,P<0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(0.56±0.10比1, t=15.68,P<0.05).(2)与对照组相比,1、10、100 nmol/L浓度Exendin-4对T1DM患者PBMC活力无明显影响(F=0.362、0.393、0.374,均P>0.05).(3)与对照组相比,10、100 nmol/L Exendin-4上调PBMC中cAMP水平(7.51±0.01比2.56±0.01,17.21±0.04比2.56±0.01,t=19.71、32.89,P<0.05).(4)与对照组相比,Exendin-4显著下调PBMC细胞中TNF-α mRNA及上清液中TNF-α水平(F=5.54、5.12,P<0.05),此种效应能够被GLP-1R阻断剂Exendin-9(39)阻断(F=5.43、5.97,P<0.05);同时Exendin-4可上调上清液中IL-10水平(F=5.95、6.01,P<0.05).结论 Exendin-4可上调IL-10的分泌,下调TNF-α的分泌,提示其可能抑制炎症反应.
Abstract_FL Objective To investigate the immunoregulation effects of Exendin-4 on peripheral blood mononuclear cells (PBMC) in patients with type 1 diabetes mellitus (T1DM). Methods PBMC samples from 11 T1DM subjects were used to investigate the effects of Exendin-4 on PBMCs in vitro. Intervention group (0, 10, 100 nmol/L) and antagonist group (50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4)were set according to the concentration of cyclic adenosine monophospphate(cAMP)in PBMCs. Cytokines[interleukin(IL)10,tumor necrosis factor α(TNF-α)]were measured by cytometric bead array and real-time quantitative PCR(RT-qPCR)analysis,respectively.Results (1)GLP-1R was detected in PBMC of T1DM.Compared with control group,the expression of GLP-1R mRNA was significantly increased in 100 nmol/L Exendin-4 treated group (1.97 ± 0.24 vs 1, P<0.05), and was inhibited by GLP-1R antagonist Exendin-9(39)(0.56±0.10 vs 1,P<0.05).(2)Compared with the control group,1 10 100 nmol/L Exendin-4 had no significant effects on PBMC activity in patients with T1DM(F=0.362,0.393,0.374,all P>0.05).(3)10 nmol/L and 100 nmol/L Exendin-4 had significant effects on levels of cAMP(7.51±0.01 vs 2.56±0.01, 17.21±0.04 vs 2.56±0.01,respectively,both P<0.05).(4)The mRNA expression levels of TNF-α,TNF-α levels in the cellular supernatant were significantly decreased after Exendin-4 intervention(F=5.54,5.12,P<0.05),and was inhibited by GLP-1R antagonist Exendin-9(39)(F=5.43,5.97,P<0.05).The levels of IL-10 in supernatant were elevated (F=5.95,6.01, P<0.05) although IL-10 mRNA levels maintained stable in PBMC. Conclusion Exendin-4 could down-regulate TNF-α secretion and up-regulate IL-10 secretion in PBMC of T1DM patients. These results suggest that exendin-4 might down-regulate pro-inflammatory responses.
Author 李霞;雷康;俞海波;段仙兰;彭亚妮;周智广
AuthorAffiliation 中南大学湘雅二医院内分泌代谢科中南大学糖尿病免疫学教育部重点实验室国家代谢性疾病临床医学研究中心,长沙410011
AuthorAffiliation_xml – name: 中南大学湘雅二医院内分泌代谢科中南大学糖尿病免疫学教育部重点实验室国家代谢性疾病临床医学研究中心, 长沙,410011
Author_FL Yu Haibo
Zhou Zhiguang
Li Xia
Peng Yani
Duan Xianlan
Lei Kang
Author_FL_xml – sequence: 1
  fullname: Li Xia
– sequence: 2
  fullname: Lei Kang
– sequence: 3
  fullname: Yu Haibo
– sequence: 4
  fullname: Duan Xianlan
– sequence: 5
  fullname: Peng Yani
– sequence: 6
  fullname: Zhou Zhiguang
Author_xml – sequence: 1
  fullname: 李霞;雷康;俞海波;段仙兰;彭亚妮;周智广
BookMark eNo90E1LAkEcBvA5GGTml-gQXdzmZWd35xjSGwhd7Cy7szu6kmO5RdRJNIMKD1EZREhSB6lDQhcjrC_juNu3aMPo9IeHH88fnjmQkFXpAbCEoEZMAy7ziq2VNT8IpIYMU89QCzINQ2RqsYCQJkDyP58F6SDwHYgQgwxClATb49GVeupEZ5-q1_1uPEaNkXp9R6p7Eb511OArvG1N4rTeipG67Ee9umrfjIfPk4dh-HEaNbvh3YlqtcPOSzRoRueN8eg-vO7Pgxlh7wRe-u-mQH5tNZ_dyOS21jezK7kMpxbNYAZ1whjHwnFdF3LBILZ0kxhIYC4wYZxy5DCku56HqIeI8CAV2PKYwXRBXZICi9PaQ1sKWxYL5epBTcYPC8elfen8joBgPEEMF6aQl6qyuOfHdLfmV-zaUcEwiYWZiSj5AWosgFQ
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.1674-5809.2017.10.005
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Immunoregulation effects of Exendin-4 on peripheral blood mononuclear cells in patients with type 1 diabetes mellitus
DocumentTitle_FL Immunoregulation effects of Exendin-4 on peripheral blood mononuclear cells in patients with type 1 diabetes mellitus
EndPage 621
ExternalDocumentID zhtnb201710005
673829715
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
ID FETCH-LOGICAL-c585-2904399c2fbddd0cf902847361f2cf239c5c1b914dee15e13fe05f28e9694f5d3
ISSN 1674-5809
IngestDate Thu May 29 04:06:42 EDT 2025
Wed Feb 14 09:56:11 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords 糖尿病,1型
type 1
艾塞那肽
Immunoregulation
Diabetes mellitus
胰高血糖素样肽1受体
免疫调节
Exendin-4
Glucagon-like peptide-1 receptor
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c585-2904399c2fbddd0cf902847361f2cf239c5c1b914dee15e13fe05f28e9694f5d3
Notes Objective To investigate the immunoregulation effects of Exendin-4 on peripheral blood mononuclear cells (PBMC) in patients with type 1 diabetes mellitus (T1DM). Methods PBMC samples from 11 T1DM subjects were used to investigate the effects of Exendin-4 on PBMCs in vitro. Intervention group (0, 10, 100 nmol/L) and antagonist group (50 nmol/L Exendin 9(39)+100 nmol/L Exendin-4)were set according to the concentration of cyclic adenosine monophospphate(cAMP)in PBMCs. Cytokines[interleukin(IL)10,tumor necrosis factor α(TNF-α)]were measured by cytometric bead array and real-time quantitative PCR(RT-qPCR)analysis,respectively.Results (1)GLP-1R was detected in PBMC of T1DM.Compared with control group,the expression of GLP-1R mRNA was significantly increased in 100 nmol/L Exendin-4 treated group (1.97 ± 0.24 vs 1, P〈0.05), and was inhibited by GLP-1R antagonist Exendin-9(39)(0.56±0.10 vs 1,P〈0.05).(2)Compared with the control group,1 10 100 nmol/L Exendin-4 had no significant effects on PBMC activity in patients wit
PageCount 5
ParticipantIDs wanfang_journals_zhtnb201710005
chongqing_primary_673829715
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 中华糖尿病杂志
PublicationTitleAlternate CHINESE JOURNAL OF DIABETES MELLITUS
PublicationTitle_FL Chinese Journal of Diabetes Mellitus
PublicationYear 2017
Publisher 中南大学湘雅二医院内分泌代谢科中南大学糖尿病免疫学教育部重点实验室国家代谢性疾病临床医学研究中心, 长沙,410011
Publisher_xml – name: 中南大学湘雅二医院内分泌代谢科中南大学糖尿病免疫学教育部重点实验室国家代谢性疾病临床医学研究中心, 长沙,410011
SSID ssib011909001
ssib048413644
ssib007286532
ssib017477303
ssib003003870
ssib051368295
Score 2.0888815
Snippet 目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研...
目的 探讨体外艾塞那肽(Exendin-4)对1型糖尿病(T1DM)患者外周血单个核细胞(PBMC)的免疫调节作用.方法 通过密度梯度离心法分离11例T1DM患者外周血PBMC,体外研究Exendin-4...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 617
SubjectTerms 1型
免疫调节
糖尿病
胰高血糖素样肽1受体
艾塞那肽
Title 体外艾塞那肽对1型糖尿病患者外周血单个核细胞的免疫调节作用
URI http://lib.cqvip.com/qk/71184X/201710/673829715.html
https://d.wanfangdata.com.cn/periodical/zhtnb201710005
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  issn: 1674-5809
  databaseCode: ABDBF
  dateStart: 20150701
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssib011909001
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9VAcKktiBdRVKz1owcXvOSZj91k95jty6MIemqht0c-W0Rf_Xi99FRaK6j0IGoFkWLRQ9GDBS8Vqf6Zpu_5L5zZpHlBxFovYd58ZGZ2k51J3syGkKsQlGMI_I4RQ7AxGIsyI0wzZqRZaoZemkaRiQ3ON2-5k9PsxgyfGTp2p1a1tNCNGvHiH_tK_mdWAQfzil2yR5jZ6qSAABjmF44ww3D8pzmmAaOqSaVDA059RqVLA0GFpCrQGItKACQVNvUdTbKRH0ktqqSFEHAIRQOPKkfLc6pMqlqIkR4VnAZuTd7UmEoZiFvUF0gCZUAFjACDuLYMkD6K-ybCqEJRUZjoaMtAhU8F01JaEDHAr5AHzBCFUh8NKF2d0DwMlNbT6gN1zdIAERzikWzqc3LEyyoUH1D0oIEqsNFRGlZUeZrdRwCRTIsGKKK4prqo0Lc1FZwIEI9sikpZugiGIJWjK2gswxPCGOCIapGCWg6qi4JKUxUArfobmqIVtQwnrscMLkxZjzeyfluZteDhlqJFHuIWneO_hzgsYoLrMr4bNm5rJY1KCRYqeg1dq8gH4b0qusTvu9rSwx0ZRmwP8rJhMuKrpmrV1nssZhis3x62LQ_6ji1IHuVBmQL-hkdRCBDV-s4EZETuIF3k8As0YhVxZeNxcq104vphLuBuJ3Pzndn7kMPplrpOFnZma9nf1ClysnxsG_eLe_A0GVqcO0Om93Zf5B_W-0--55sbP5ff95d3889frXzjWe_Ler79o_d6dR-wS6vAlD_f6m8u5Wuv9nY-7r_b6X173F_Z6L15lK-u9dY_9bdX-k-X93bf9l5unSVTrWBqYtIoP1NixPCsbdgSu8tlbGdRkiRmnOF-SMxzXCuz48x2ZMxjK5IWS9LU4qnlwCrIM1uk0pUs44lzjgx35jvpeTIeMpGEacQcwDOZJWHE3MhMw9CUmZ1E3igZq0akfa_YjaZdTesouVKOUbtcox62F-e6nQjHFP_G4xf-Kj9GTiBn8X7xIhnuPlhIL0HG3Y0ulxfKL2R1qTw
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%BD%93%E5%A4%96%E8%89%BE%E5%A1%9E%E9%82%A3%E8%82%BD%E5%AF%B91%E5%9E%8B%E7%B3%96%E5%B0%BF%E7%97%85%E6%82%A3%E8%80%85%E5%A4%96%E5%91%A8%E8%A1%80%E5%8D%95%E4%B8%AA%E6%A0%B8%E7%BB%86%E8%83%9E%E7%9A%84%E5%85%8D%E7%96%AB%E8%B0%83%E8%8A%82%E4%BD%9C%E7%94%A8&rft.jtitle=%E4%B8%AD%E5%8D%8E%E7%B3%96%E5%B0%BF%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E6%9D%8E%E9%9C%9E%3B%E9%9B%B7%E5%BA%B7%3B%E4%BF%9E%E6%B5%B7%E6%B3%A2%3B%E6%AE%B5%E4%BB%99%E5%85%B0%3B%E5%BD%AD%E4%BA%9A%E5%A6%AE%3B%E5%91%A8%E6%99%BA%E5%B9%BF&rft.date=2017&rft.issn=1674-5809&rft.volume=9&rft.issue=10&rft.spage=617&rft.epage=621&rft_id=info:doi/10.3760%2Fcma.j.issn.1674-5809.2017.10.005&rft.externalDocID=673829715
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F71184X%2F71184X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhtnb%2Fzhtnb.jpg